Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States of America.
Department of Neurology, Albany Medical Center, Albany, NY, United States of America.
Exp Neurol. 2019 Jul;317:155-167. doi: 10.1016/j.expneurol.2019.03.008. Epub 2019 Mar 16.
Parkinson's disease (PD) is a neurodegenerative disease with affected individuals exhibiting motor symptoms of bradykinesia, muscle rigidity, tremor, postural instability and gait dysfunction. The current gold standard treatment is pharmacotherapy with levodopa, but long-term use is associated with motor response fluctuations and can cause abnormal movements called dyskinesias. An alternative treatment option is deep brain stimulation (DBS) with the two FDA-approved brain targets for PD situated in the basal ganglia; specifically, in the subthalamic nucleus (STN) and globus pallidus pars interna (GPi). Both improve quality of life and motor scores by ~50-70% in well-selected patients but can also elicit adverse effects on cognition and other non-motor symptoms. Therefore, identifying a novel DBS target that is efficacious for patients not optimally responsive to current DBS targets with fewer side-effects has clear clinical merit. Here, we investigate whether the ventroanterior (VA) and ventrolateral (VL) motor nuclei of the thalamus can serve as novel and effective DBS targets for PD. In the limb-use asymmetry test (LAT), hemiparkinsonian rats showcased left forelimb akinesia and touched only 6.5 ± 1.3% with that paw. However, these animals touched equally with both forepaws with DBS at 10 Hz, 100 μsec pulse width and 100 uA cathodic stimulation in the VA (n = 7), VL (n = 8) or at the interface between the two thalamic nuclei which we refer to as the VA|VL (n = 12). With whole-cell patch-clamp recordings, we noted that VA|VL stimulation in vitro increased the number of induced action potentials in proximal neurons in both areas albeit VL neurons transitioned from bursting to non-bursting action potentials (APs) with large excitatory postsynaptic potentials time-locked to stimulation. In contrast, VA neurons were excited with VA|VL electrical stimulation but with little change in spiking phenotype. Overall, our findings show that DBS in the VA, VL or VA|VL improved motor function in a rat model of PD; plausibly via increased excitation of residing neurons.
帕金森病(PD)是一种神经退行性疾病,受影响的个体表现出运动症状,如运动迟缓、肌肉僵硬、震颤、姿势不稳和步态障碍。目前的金标准治疗是使用左旋多巴进行药物治疗,但长期使用与运动反应波动有关,并可能导致称为运动障碍的异常运动。替代治疗选择是深部脑刺激(DBS),FDA 批准的用于 PD 的两个大脑靶点位于基底神经节;具体来说,在丘脑底核(STN)和苍白球内节(GPi)。在经过精心选择的患者中,这两种方法都可以使生活质量和运动评分提高约 50-70%,但也可能对认知和其他非运动症状产生不良反应。因此,确定一种新的 DBS 靶点,对于当前 DBS 靶点治疗反应不佳的患者有效,且副作用较少,具有明显的临床价值。在这里,我们研究了丘脑腹前(VA)和腹外侧(VL)运动核是否可以作为 PD 的新型有效 DBS 靶点。在肢体使用不对称性测试(LAT)中,偏侧帕金森大鼠表现出左前肢运动迟缓,仅用该爪子触摸 6.5±1.3%。然而,当在 VA(n=7)、VL(n=8)或两个丘脑核之间的界面(我们称之为 VA|VL,n=12)以 10Hz、100μsec 脉冲宽度和 100uA 阴极刺激进行 DBS 时,这些动物用两只前脚同样地触摸。通过全细胞贴片记录,我们注意到,在体外,VA|VL 刺激增加了两个区域近端神经元诱导动作电位的数量,尽管 VL 神经元从爆发到非爆发动作电位(AP)过渡,具有与刺激时间锁定的大兴奋性突触后电位。相比之下,VA 神经元在 VA|VL 电刺激下被兴奋,但放电表型变化不大。总的来说,我们的发现表明,在 PD 大鼠模型中,VA、VL 或 VA|VL 的 DBS 改善了运动功能;可能是通过增加驻留神经元的兴奋。